# Real Protocol Intelligence Dataset Summary

## Data Collection
- **Collection Date**: 2025-09-21T22:33:12.726Z
- **Data Source**: ClinicalTrials.gov API v2
- **Total Protocols Analyzed**: 127
- **Total Studies**: 125

## Phase Distribution
- **PHASE2**: 29 protocols
- **NA**: 39 protocols
- **PHASE3**: 21 protocols
- **PHASE1**: 12 protocols
- **EARLY_PHASE1**: 1 protocols
- **PHASE4**: 7 protocols

## Complexity Analysis
- **Median Complexity Score**: 87
- **Complexity Range**: 14 - 100
- **Complexity Categories**: Highly Complex(80), Moderate(15), Complex(29), Simple(3)

## Enrollment Analysis
- **Median Enrollment**: 128
- **Enrollment Range**: 1 - 14105

## Eligibility Criteria Analysis
- **Median Criteria Count**: 12
- **Criteria Range**: 0 - 84

## Real Benchmarks by Phase

### PHASE2
- Sample Size: 29 protocols
- Complexity: median=100
- Enrollment: median=76
- Criteria: median=23


### NA
- Sample Size: 39 protocols
- Complexity: median=71
- Enrollment: median=60
- Criteria: median=7


### PHASE3
- Sample Size: 21 protocols
- Complexity: median=100
- Enrollment: median=428
- Criteria: median=22


### PHASE1
- Sample Size: 12 protocols
- Complexity: median=100
- Enrollment: median=37
- Criteria: median=30.5


### EARLY_PHASE1
- Sample Size: 1 protocols
- Complexity: median=100
- Enrollment: median=6
- Criteria: median=8


### PHASE4
- Sample Size: 7 protocols
- Complexity: median=87
- Enrollment: median=87
- Criteria: median=16


## Key Insights
- Real protocol data shows significant variation in complexity across phases
- Actual enrollment sizes vary widely within phases
- Eligibility criteria counts provide good complexity indicators
- This dataset enables real benchmarking vs. mock data

*Generated by Real Protocol Intelligence Collector*
